RANITIDINE HYDROCHLORIDE FOR INJECTION MARKET

INTRODUCTION

Ranitidine hydrochloride , sold under the brand name Zantac among others, is a medication used to decrease stomach acid production. It is commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It can be given by mouth, injection into a muscle, or injection into a vein.

In September last year , the probable carcinogen N-nitroso dimethylamine (NDMA) was discovered in ranitidine products from a number of manufacturers, resulting in recalls. In April , ranitidine was withdrawn from the United States market and suspended in the European Union and Australia due to these concerns. 

Common side effects include headaches and pain or burning if given by injection. Serious side effects may include cancer, liver problems, a slow heart rate, pneumonia, and the potential of masking stomach cancer. It is also linked to an increased risk of Clostridium difficile colitis.

Ranitidine is an H2 histamine receptor antagonist that works by blocking histamine, thus decreasing the amount of acid released by cells of the stomach. For prevention of acid-aspiration pneumonitis during surgery, it can be administered preoperatively. The drug increases gastricpH, but generally has no effect on gastric volume.

RANITIDINE HYDROCHLORIDE FOR INJECTION MARKET SIZE AND FORECAST

The Global Ranitidine Hydrochloride for Injection Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

RANITIDINE HYDROCHLORODE FOR INJECTION MARKET NEW PRODUCT LAUNCH

PFIZER RANITIDINE HYDROCHLORIDERANITIDINE Hydrochloride belongs to the class of gastrointestinal agents. It is used to treat indigestion, heartburn and acid reflux.

RANITIDINE is also used for gastro-esophageal reflux disease (GORD) when you get acid reflux. RANITIDINE is also used to prevent and treat stomach ulcers. Often RANITIDINE is taken for a rare condition caused by a pancreatic or intestine tumors called Zollinger-Ellison Syndrome.

RANITIDINE contains ranitidine, a histamine-2 (H2) receptor blocker that helps reduce stomach acid by blocking the actions of the H2 receptor. The H2 receptor lies in the parietal cells of the stomach wall and is responsible for the release of gastric acid secretion - extra gastric acid secretion damage the tissues in the food pipe, stomach, and duodenum.

RANITIDINE HYDROCHLORIDE FOR INJECTION MARKET COMPANY PROFILE

• CIPLA 
• GLENMARK
• DR REDDY
• SUN PHARMA
• ALKEM

THIS RANITIDINE HYDROCHLORIDE FOR INJECTION MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Ranitidine Hydrochloride for Injection are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Ranitidine Hydrochloride for Injection and key vendor selection criteria
3. Where is the Ranitidine Hydrochloride for Injection manufactured? What is the average margin per unit?
4. Market share of Global Ranitidine Hydrochloride for Injection market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Ranitidine Hydrochloride for Injection in-house
6. key predictions for next 5 years in Global Ranitidine Hydrochloride for Injection market
7. Average B-2-B Ranitidine Hydrochloride for Injection market price in all segments
8. Latest trends in Ranitidine Hydrochloride for Injection market, by every market segment
9. The market size (both volume and value) of the Ranitidine Hydrochloride for Injection market in 2024-2030 and every year in between?
10. Production breakup of Ranitidine Hydrochloride for Injection market, by suppliers and their OEM relationship